These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 1497007)
1. Rapid intravenous infusion of amphotericin B: a pilot study. Cruz JM; Peacock JE; Loomer L; Holder LW; Evans GW; Powell BL; Lyerly ES; Capizzi RL Am J Med; 1992 Aug; 93(2):123-30. PubMed ID: 1497007 [TBL] [Abstract][Full Text] [Related]
2. Amphotericin B revisited: reassessment of toxicity. Clements JS; Peacock JE Am J Med; 1990 May; 88(5N):22N-27N. PubMed ID: 2368770 [TBL] [Abstract][Full Text] [Related]
3. Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions. Nicholl TA; Nimmo CR; Shepherd JD; Phillips P; Jewesson PJ Ann Pharmacother; 1995 Nov; 29(11):1081-7. PubMed ID: 8573948 [TBL] [Abstract][Full Text] [Related]
4. Must we really fear toxicity of conventional amphotericin B in oncological patients? Mayer J; Doubek M; Vorlìcek J Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976 [TBL] [Abstract][Full Text] [Related]
5. Amphotericin B toxicity reduced by administration in fat emulsion. Anderson RP; Clark DA Ann Pharmacother; 1995 May; 29(5):496-500. PubMed ID: 7655134 [TBL] [Abstract][Full Text] [Related]
6. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate. Maharom P; Thamlikitkul V J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252 [TBL] [Abstract][Full Text] [Related]
7. [The influence of the duration of infusion on the acute toxicity of amphotericin B. Comparison of two hour versus four hour infusions]. Arning M; Aul C; Dresen B; Schneider W Immun Infekt; 1991 Jun; 19(3):80-3. PubMed ID: 1916869 [TBL] [Abstract][Full Text] [Related]
8. Effect of infusion rate on amphotericin B-associated febrile reactions. Cleary JD; Weisdorf D; Fletcher CV Drug Intell Clin Pharm; 1988 Oct; 22(10):769-72. PubMed ID: 3068038 [TBL] [Abstract][Full Text] [Related]
9. Potential Usefulness of Early Potassium Supplementation for Preventing Severe Hypokalemia Induced by Liposomal Amphotericin B in Hematologic Patients: A Retrospective Study. Okada N; Azuma M; Imanishi M; Zamami Y; Kirino Y; Nakamura T; Teraoka K; Abe M; Ishizawa K Clin Ther; 2018 Feb; 40(2):252-260. PubMed ID: 29305017 [TBL] [Abstract][Full Text] [Related]
10. [Retrospective analysis of the safety of four hours administration of liposomal amphotericin B in patients with chronic necrotizing pulmonary aspergillosis]. Yatera K; Yamasaki K; Kozaki M; Shimauchi M; Kawanami T; Nagata S; Suzuki Y; Tokuyama S; Inoue N; Nishida C; Ishimoto H; Kawajiri T; Awaya Y; Tsuda T; Mukae H Jpn J Antibiot; 2011 Oct; 64(5):311-8. PubMed ID: 22428214 [TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411 [TBL] [Abstract][Full Text] [Related]
12. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia. Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial. Hasibi M; Jafari S; Manshadi SA; Asadollahi M; Salehi M; Zarch VV; Kouhi A Ear Nose Throat J; 2017 Feb; 96(2):E18-E22. PubMed ID: 28231371 [TBL] [Abstract][Full Text] [Related]
14. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. Chavanet PY; Garry I; Charlier N; Caillot D; Kisterman JP; D'Athis M; Portier H BMJ; 1992 Oct; 305(6859):921-5. PubMed ID: 1458072 [TBL] [Abstract][Full Text] [Related]
15. Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication. Oto OA; Paydas S; Disel U; Yavuz S; Seydaoglu G Mycoses; 2007 Mar; 50(2):135-9. PubMed ID: 17305778 [TBL] [Abstract][Full Text] [Related]
16. Controlled pilot study of rapid amphotericin B infusions. Dele Davies H; King SM; Doyle J; Matlow A; Koren G; Hamilton R; Portwine C Arch Dis Child; 1997 Feb; 76(2):165-6. PubMed ID: 9068312 [TBL] [Abstract][Full Text] [Related]
17. [Amphotericin B deoxycholate prescription and adverse events in a Chilean university hospital]. Quinteros A R; Fica C A; Abusada A N; Muñoz C L; Novoa M C; Gallardo A C Rev Chilena Infectol; 2010 Feb; 27(1):25-33. PubMed ID: 20140311 [TBL] [Abstract][Full Text] [Related]
18. Risk factors of amphotericin B toxicty in the nonneonatal pediatric population. Dutta A; Palazzi DL Pediatr Infect Dis J; 2012 Sep; 31(9):910-4. PubMed ID: 22581225 [TBL] [Abstract][Full Text] [Related]